INTERNATIONAL PATENT: CHONG KUN DANG PHARMACEUTICAL CORP. FILES APPLICATION FOR "PHARMACEUTICAL COMBINATION FORMULATION COMPRISING ATORVASTATIN AND EZETIMIBE"

GENEVA, Nov. 4 -- CHONG KUN DANG PHARMACEUTICAL CORP. (8, Chungjeong-roSeodaemun-guSeoul 03742) filed a patent application (PCT/KR2025/005450) for "PHARMACEUTICAL COMBINATION FORMULATION COMPRISING ATORVASTATIN AND EZETIMIBE" on Apr 23, 2025. With publication no. WO/2025/226020, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEE, Jewon (315-20 Dongbaekjukjeon-daero, Giheung-guYongin-siGyeonggi-do 16995), KIM, Junheon (315-20 Dongbaekjukjeon-daero, Giheung-guYongin-siGyeonggi-do 16995), HAN, Sungkyun (315-20 Dongbaekjukje...